Table 4.
Parameter | Timepoint | UC-II | Placebo | SEM | P-value |
---|---|---|---|---|---|
FRK Inflammation Index | Baseline | 67.62 | 67.57 | 2.20 | 0.988 |
Pre 5 km | 64.14 | 67.76 | 2.08 | 0.220 | |
24 h post 5 km | 65.20 | 71.62 | 2.10 | 0.032 | |
48 h post 5 km | 64.18 | 65.74 | 2.02 | 0.587 | |
Pre 16 km | 60.62 | 64.06 | 1.99 | 0.228 | |
24 h post 16 km | 61.49 | 67.79 | 1.99 | 0.029 | |
48 h post 16 km | 64.23 | 70.45 | 2.45 | 0.073 | |
FRK Inflammation Index Change | Baseline vs pre 5 km | –6.60 | 0.65 | 1.63 | 0.003 |
Pre 5 km vs 24 h post 5 km | 0.63 | 0.97 | 1.79 | 0.893 | |
Pre 5 km vs 48 h post 5 km | –1.95 | –2.58 | 2.09 | 0.832 | |
Pre 16 km vs 24 h post 16 km | 2.04 | 6.94 | 1.50 | 0.028 | |
Pre 16 km vs 48 h post 16 km | 1.55 | 10.44 | 1.55 | 0.027 |
Timepoints include prior to starting treatments or exercise (baseline), prior to the first 5 km run (pre 5 km), 24 h after the first 5 km run (24 h post 5 km), 48 h after the first 5 km run (48 h post 5 km) prior to the final 16 km run (pre 16 km), 24 h after the final 16 km run (post 16 km), and 48 h after the final 16 km run (48 h post 16 km). Values are presented as least squared means with their standard error.